Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase complex assembly factor 3 (NDUFAF3) is a mitochondrial protein essential for the assembly of complex I (NADH:ubiquinone oxidoreductase) in the electron transport chain[1][2][3][5][6]. It interacts with complex I subunits and is required for the biogenesis of this large enzymatic complex, enabling proper cellular respiration and energy production[1][2]. Mutations in NDUFAF3 can cause severe mitochondrial complex I deficiency, often presenting as fatal neonatal metabolic disorders or Leigh syndrome, highlighting its critical role in mitochondrial bioenergetics[2]. As an assembly factor, it does not directly act as an enzyme or druggable target, but dysfunction of this protein contributes significantly to mitochondrial diseases[1][2][4]. NDUFAF3 acts in concert with other assembly factors, such as NDUFAF4, during early steps of complex I formation[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase complex assembly factor 3 (NDUFAF3).